| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.001 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.006 |